RESUMEN
With the increasing digitalization and informatization of distribution network systems, distribution networks have gradually developed into distribution network cyber physical systems (CPS) which are deeply integrated with traditional power systems and cyber systems. However, at the same time, the network risk problems that the cyber systems face have also increased. Considering the possible cyber attack vulnerabilities in the distribution network CPS, a dynamic Bayesian network approach is proposed in this paper to quantitatively assess the security risk of the distribution network CPS. First, the Bayesian network model is constructed based on the structure of the distribution network and common vulnerability scoring system (CVSS). Second, a combination of the fuzzy analytic hierarchy process (FAHP) and entropy weight method is used to correct the selectivity of the attacker to strike the target when cyber attack vulnerabilities occur, and then after considering the defense resources of the system, the risk probability of the target nodes is obtained. Finally, the node loads and node risk rates are used to quantitatively assess the risk values that are applied to determine the risk level of the distribution network CPS, so that defense strategies can be given in advance to counter the adverse effects of cyber attack vulnerabilities.
RESUMEN
Erythropoietin (EPO) is an attractive protein-unfolding/folding model because of its high degree of unfolding and folding reversibility and intermediate size. Due to its function for regulating red blood cell production by stimulating late erythroid precursor cells, EPO presents obvious values to biological research. A nonemissive anthracene derivative, that is 9,10-bis[4-(3-sulfonatopropoxyl)-styryl]anthracene sodium salt (BSPSA), with aggregation-induced emission (AIE) charateristics shows a novel phenomenon of AIE when EPO is added. The AIE biosensor for EPO shows the limit of detection is 1 × 10(-9) M. Utilizing the AIE feature of BSPSA, the unfolding process of EPO using guanidine hydrochloride is monitored, which indicates three steps for the folding structures of EPO to transform to random coil. Computational modeling suggests that the BSPSA luminogens prefer docking in the hydrophobic cavity in the EPO folding structures, and the assembly of BSPSA in this cavity makes the AIE available, making the monitoring of unfolding of EPO possible.
Asunto(s)
Antracenos/química , Diseño de Fármacos , Eritropoyetina/química , Técnicas de Sonda Molecular , Sondas Moleculares/química , Pliegue de Proteína , Antracenos/síntesis química , Antracenos/metabolismo , Eritropoyetina/metabolismo , Simulación del Acoplamiento Molecular , Sondas Moleculares/síntesis química , Sondas Moleculares/metabolismo , Conformación Proteica , SolucionesRESUMEN
Combining electrophoresis with a cellulose acetate membrane-based technique, we developed a simple and low-cost method, named cellulose acetate membrane-based small lanes (CASL), for protein electrophoresis. A home-made capillary plotter controlled by a 3D moving stage was used to create milli-to-micro channels by printing poly(dimethylsiloxane) on to a hydrophilic cellulose acetate membrane. In the hydrophilic channels, 5 nL protein mixture was separated on the basis of electro-migration under an electric field. Compared with polyacrylamide gel electrophoresis (PAGE), CASL resulted in higher protein signal intensity for separation of mixtures containing the same mass of protein. The platform was easily fabricated at low cost (approx. $0.005 for each 1-mm-wide channel), and separation of three protein mixtures was completed in 15 min. Both electrophoresis time and potential affected the separation. Rather than chromatographic separation, this method accomplished application of microchannel techniques for cellulose acetate membrane-based protein electrophoresis. It has potential in proteomic analysis, especially for rapid, low-cost, and low-volume sample analysis in clinical diagnosis.
Asunto(s)
Celulosa/análogos & derivados , Electroforesis en Acetato de Celulosa/métodos , Técnicas Analíticas Microfluídicas/métodos , Celulosa/química , Dimetilpolisiloxanos/química , Electroforesis en Acetato de Celulosa/instrumentación , Electroforesis en Gel de Poliacrilamida , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Inmunoglobulina G/química , Límite de Detección , Membranas Artificiales , Técnicas Analíticas Microfluídicas/instrumentación , Peso Molecular , Albúmina Sérica/química , Transferrina/químicaRESUMEN
This paper describes the applications of multifunctional magnetic nanoparticles (MNPs) for the enrichment of low-abundance proteins for polyacrylamide gel electrophoresis (PAGE) separation. The hemoglobin-functionalized MNPs, named Hb-MNPs, were obtained based on electrostatic interactions and covalent binding between the hemoglobin (Hb) and the MNPs. It was demonstrated that the proteins in human serum were selectively conjugated to Hb-MNPs, which can be used for the selective enrichment of low-abundance proteins. Three and seven kinds of proteins were identified by MS after 1-D and 2-D PAGE, respectively. Comparing with native PAGE without the treatment of MNPs, some proteins were observed, such as human serum amyloid P component (SAP), vitamin D-binding protein, and serine peptidase inhibitor. Because the high concentration of SAP can be considered as a signal for the neurodegeneration of Alzheimer's disease, the present Hb-MNPs-based method was applied to investigate the serum level of SAP for the diagnosis of Alzheimer's disease, and the results are satisfying.
Asunto(s)
Proteínas Sanguíneas/aislamiento & purificación , Electroforesis en Gel de Poliacrilamida/métodos , Nanopartículas de Magnetita/química , Enfermedad de Alzheimer/metabolismo , Proteínas Sanguíneas/análisis , Proteínas Sanguíneas/química , Hemoglobinas/química , Hemoglobinas/metabolismo , Humanos , Proteínas Inmovilizadas/química , Proteínas Inmovilizadas/metabolismo , Espectrometría de Masas/métodos , Componente Amiloide P Sérico/química , Componente Amiloide P Sérico/metabolismoRESUMEN
BACKGROUND: Glycoprotein IIb/IIIa inhibitors (GPIs) have been regarded as an adjuvant regimen to deal with no-reflow. However, whether intralesional (IL) administration of GPIs improves myocardial reperfusion without increasing bleeding in patients with acute coronary syndrome (ACS) compared with intracoronary (IC) administration has not been well addressed. Our meta-analysis aimed to evaluate the efficacy and safety of IL versus IC administration of GPIs for patients with ACS during percutaneous coronary intervention. METHODS: We systematically searched Medline, Embase, the Cochrane Central Register of Controlled Trials, and Cambridge Scientific Abstracts from January 2007 to May 2017. Thrombolysis in Myocardial Infarction (TIMI) 3 flow, corrected TIMI frame count (CTFC), and complete ST-segment resolution (>70%) were selected as the primary outcomes. Major adverse cardiac events (MACEs) were the secondary outcome, and major bleeding complications were the safety outcome. Data analysis was conducted using the Review Manager 5.3 software. RESULTS: Six randomized controlled trials were included in our meta-analysis. Compared with IC, IL obtained better results in terms of TIMI grade 3 flow [odds ratio (OR) 2.29; 95% confidence intervals (CIs) 1.31-4.01; Pâ=â.004], CTFC [weighted mean difference (WMD) -4.63; 95% CI -8.82 to -0.43; Pâ=â.03], and complete ST-segment resolution (OR 1.55; 95% CI 1.12-2.14; Pâ=â.008). There was a trend toward decreased MACE in the IL administration groups, which was not of statistical significance (OR 0.63; 95% CI 0.30-1.31; Pâ=â.22). No significant difference was found between the two groups in terms of in-hospital major bleeding events (OR 2.52; 95% CI .66 to 9.62; Pâ=â.18). CONCLUSION: IL administration yielded favorable outcomes in terms of myocardial tissue reperfusion as evidenced by the improved TIMI flow grade, CTFC, complete ST-segment resolution, and decreased MACE without increasing in-hospital major bleeding events. The IL administration of GPIs can be recommended as the preferred regimen to guard against no-reflow.